Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic…
Clarivate Unveils the 2025 Journal Citation Reports
50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON, June 18,…
Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology
CAESAREA, Israel, June 17, 2025 /PRNewswire/ -- A newly published, peer-reviewed study…
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results
June 16, 2025 18:40 ET | Source: Enzo Biochem, Inc. FARMINGDALE, N.Y.,…
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
11 of 12 participants (92%) enrolled in the 180mg cohort achieved a…
Automation Anywhere Reports Strong Q1 Fiscal Year 2026 Growth and Profitability, Driven by Increased Demand for the Agentic Process Automation System
At Imagine 2025, Automation Anywhere Extended its Lead in AI Innovation with…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025 16:30 ET | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025 16:30 ET | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO,…
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2025 17:00 ET | Source: Anika Therapeutics Inc. BEDFORD, Mass.,…
SEMI Reports Global Semiconductor Equipment Billings Increased 21% Year-Over-Year in Q1 2025
Growth driven by AI demand and fab expansion MILPITAS, Calif., June 6,…
